A citation-based method for searching scientific literature

Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema, Gaetano M De Ferrari, Witold Ruzyllo, Paul De Lucca, KyungAh Im, Erin A Bohula, Craig Reist, Stephen D Wiviott, Andrew M Tershakovec, Thomas A Musliner, Eugene Braunwald, Robert M Califf. N Engl J Med 2015
Times Cited: 2202



Louise Bowman, Jemma C Hopewell, Fang Chen, Karl Wallendszus, William Stevens, Rory Collins, Stephen D Wiviott, Christopher P Cannon, Eugene Braunwald, Emily Sammons, Martin J Landray. N Engl J Med 2017
Times Cited: 526




List of shared articles



Times cited

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno,[...]. Eur J Prev Cardiol 2022
18

Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Treated With Statins.
Daigo Takahashi, Hideki Wada, Manabu Ogita, Kentaro Yasuda, Ryota Nishio, Mitsuhiro Takeuchi, Jun Shitara, Shuta Tsuboi, Tomotaka Dohi, Satoru Suwa,[...]. Am J Cardiol 2022
0

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
Tom G Richardson, Genevieve M Leyden, Qin Wang, Joshua A Bell, Benjamin Elsworth, George Davey Smith, Michael V Holmes. PLoS Biol 2022
0

Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients With Diabetes.
Bushra Hassan Marouf, Zohaib Iqbal, Jamal Basheer Mohamad, Bilal Bashir, Jonathan Schofield, Akheel Syed, Eric S Kilpatrick, Claudia Stefanutti, Handrean Soran. Clin Ther 2022
0

Addressing dyslipidemic risk beyond LDL-cholesterol.
Alan R Tall, David G Thomas, Ainara G Gonzalez-Cabodevilla, Ira J Goldberg. J Clin Invest 2022
3

What is the Optimal Low-Density Lipoprotein Cholesterol?
Andrew Gagel, Fawzi Zghyer, Christeen Samuel, Seth S Martin. Med Clin North Am 2022
0

Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT.
Hidenori Arai, Hideaki Bujo, Daisaku Masuda, Toshiyuki Ishibashi, Satoshi Nakagawa, Kenichiro Tanabe, Tatsuo Kagimura, Hyun-Jae Kang, Moo Hyun Kim, Jidong Sung,[...]. J Atheroscler Thromb 2022
1

Emerging Cholesterol Modulators for Atherosclerotic Cardiovascular Disease.
Sangkyu Noh, Kevin Mai, Madeleine Shaver, Stanley Yong, Mirko Mostaghimi, Grace Oh, Mohamed M Radwan. Am J Med Sci 2022
0